Tories: UK should have central role in Ukraine peace talks Tomb of Egyptian pharaoh found in 'remarkable discovery' Ukrainian agent infiltrates 500km from the front line and destroys strategic ...

Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform.

Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on TG Therapeutics (TGTX – Research Report) today and set a price target of $10.00. The company’s shares closed ...